| 0.1 |
0.3 |
GO:0046495 |
nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
| 0.1 |
0.2 |
GO:2000646 |
positive regulation of receptor catabolic process(GO:2000646) |
| 0.1 |
0.2 |
GO:0002605 |
negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) negative regulation of dendritic cell antigen processing and presentation(GO:0002605) |
| 0.1 |
0.6 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
| 0.1 |
0.2 |
GO:0060516 |
primary prostatic bud elongation(GO:0060516) renal vesicle induction(GO:0072034) |
| 0.1 |
0.2 |
GO:0036466 |
synaptic vesicle recycling via endosome(GO:0036466) |
| 0.1 |
0.2 |
GO:0060585 |
regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 0.1 |
0.2 |
GO:0070563 |
negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 0.1 |
0.1 |
GO:1903526 |
negative regulation of membrane tubulation(GO:1903526) |
| 0.1 |
0.2 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.0 |
0.2 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.0 |
0.1 |
GO:0014740 |
negative regulation of muscle hyperplasia(GO:0014740) |
| 0.0 |
0.1 |
GO:1904956 |
neural crest cell fate commitment(GO:0014034) regulation of midbrain dopaminergic neuron differentiation(GO:1904956) regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
| 0.0 |
0.2 |
GO:1902378 |
vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 0.0 |
0.4 |
GO:1904627 |
response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.0 |
0.2 |
GO:0061032 |
visceral serous pericardium development(GO:0061032) |
| 0.0 |
0.3 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.0 |
0.1 |
GO:1902336 |
neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) positive regulation of retinal ganglion cell axon guidance(GO:1902336) regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
| 0.0 |
0.2 |
GO:1904381 |
Golgi apparatus mannose trimming(GO:1904381) |
| 0.0 |
0.1 |
GO:1900222 |
regulation of cell growth by extracellular stimulus(GO:0001560) negative regulation of beta-amyloid clearance(GO:1900222) |
| 0.0 |
0.1 |
GO:1900377 |
negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.0 |
0.1 |
GO:2001288 |
positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.0 |
0.1 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.0 |
0.1 |
GO:0031247 |
actin rod assembly(GO:0031247) |
| 0.0 |
0.1 |
GO:0042357 |
thiamine diphosphate metabolic process(GO:0042357) |
| 0.0 |
0.1 |
GO:0008050 |
female courtship behavior(GO:0008050) |
| 0.0 |
0.1 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.0 |
0.2 |
GO:0042760 |
very long-chain fatty acid catabolic process(GO:0042760) |
| 0.0 |
0.1 |
GO:0010652 |
regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
| 0.0 |
0.6 |
GO:0071481 |
cellular response to X-ray(GO:0071481) |
| 0.0 |
0.2 |
GO:0060414 |
aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.0 |
0.1 |
GO:0006041 |
glucosamine metabolic process(GO:0006041) |
| 0.0 |
0.1 |
GO:0039019 |
pronephric nephron development(GO:0039019) |
| 0.0 |
0.1 |
GO:0071651 |
positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
| 0.0 |
0.1 |
GO:1900425 |
negative regulation of defense response to bacterium(GO:1900425) |
| 0.0 |
0.2 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.0 |
0.2 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.0 |
0.1 |
GO:1903588 |
negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.0 |
0.2 |
GO:0044387 |
negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.0 |
0.1 |
GO:0097338 |
response to clozapine(GO:0097338) |
| 0.0 |
0.1 |
GO:0098746 |
fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.0 |
0.1 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) |
| 0.0 |
0.1 |
GO:0003322 |
pancreatic A cell development(GO:0003322) |
| 0.0 |
0.1 |
GO:0042247 |
morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 0.0 |
0.2 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.0 |
0.1 |
GO:2000628 |
regulation of miRNA metabolic process(GO:2000628) |
| 0.0 |
0.1 |
GO:1903385 |
regulation of homophilic cell adhesion(GO:1903385) |
| 0.0 |
0.0 |
GO:0021524 |
visceral motor neuron differentiation(GO:0021524) |
| 0.0 |
0.1 |
GO:2000639 |
regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
| 0.0 |
0.1 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.0 |
0.1 |
GO:0006408 |
snRNA export from nucleus(GO:0006408) |
| 0.0 |
0.1 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.0 |
0.0 |
GO:2000669 |
negative regulation of dendritic cell apoptotic process(GO:2000669) |
| 0.0 |
0.1 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.0 |
0.1 |
GO:0070141 |
response to UV-A(GO:0070141) |
| 0.0 |
0.0 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.0 |
0.0 |
GO:1901873 |
regulation of post-translational protein modification(GO:1901873) |
| 0.0 |
0.1 |
GO:0060372 |
regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
| 0.0 |
0.1 |
GO:0042373 |
vitamin K metabolic process(GO:0042373) |
| 0.0 |
0.0 |
GO:0015917 |
aminophospholipid transport(GO:0015917) regulation of high-density lipoprotein particle assembly(GO:0090107) |
| 0.0 |
0.2 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.0 |
0.1 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
